These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9641928)

  • 1. Effect of flutamide on survival in patients with pancreatic cancer: results of a prospective, randomised, double blind, placebo controlled trial.
    Greenway BA
    BMJ; 1998 Jun; 316(7149):1935-8. PubMed ID: 9641928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide in unresectable pancreatic adenocarcinoma: a randomized, double-blind, placebo-controlled trial.
    Negi SS; Agarwal A; Chaudhary A
    Invest New Drugs; 2006 May; 24(3):189-94. PubMed ID: 16133790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor-blocking agents: potential role in pancreatic cancer.
    Greenway BA
    Drugs Aging; 2000 Sep; 17(3):161-3. PubMed ID: 11043816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flutamide on survival in patients with pancreatic cancer. Results are impressive.
    Wigmore SJ; Fearon KC; Garden OJ
    BMJ; 1999 Jan; 318(7179):327; author reply 328. PubMed ID: 10075463
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral orchidectomy and flutamide versus orchidectomy alone in newly diagnosed patients with metastatic carcinoma of the prostate--an Australian multicentre trial.
    Zalcberg JR; Raghaven D; Marshall V; Thompson PJ
    Br J Urol; 1996 Jun; 77(6):865-9. PubMed ID: 8705223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment versus LHRH alone in advanced prostatic cancer.
    Ferrari P; Castagnetti G; Ferrari G; Baisi B; Dotti A
    Urol Int; 1996; 56 Suppl 1():13-7. PubMed ID: 8776812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
    Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
    Miyake H; Hara I; Eto H
    BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer.
    Sharma JJ; Razvillas B; Stephens CD; Hilsenbeck SG; Sharma A; Rothenberg ML
    Invest New Drugs; 1997; 15(4):361-4. PubMed ID: 9547680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?
    Bennett CL; Matchar D; McCrory D; McLeod DG; Crawford ED; Hillner BE
    Cancer; 1996 May; 77(9):1854-61. PubMed ID: 8646685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
    Fransson P; Lund JA; Damber JE; Klepp O; Wiklund F; Fosså S; Widmark A; ;
    Lancet Oncol; 2009 Apr; 10(4):370-80. PubMed ID: 19286422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
    Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
    N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is prednisolone as good as flutamide in hormone refractory metastatic carcinoma of the prostate?
    Datta SN; Thomas K; Matthews PN
    J Urol; 1997 Jul; 158(1):175-7. PubMed ID: 9186348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome.
    Peterson BS; Zhang H; Anderson GM; Leckman JF
    J Clin Psychopharmacol; 1998 Aug; 18(4):324-31. PubMed ID: 9690699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
    Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study.
    Sundblad C; Landén M; Eriksson T; Bergman L; Eriksson E
    J Clin Psychopharmacol; 2005 Feb; 25(1):85-8. PubMed ID: 15643104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of flutamide on survival in patients with pancreatic cancer. No recommendations can be made.
    Wasan HS
    BMJ; 1999 Jan; 318(7179):327-8. PubMed ID: 10075464
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
    Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ
    N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.